← Insider buys
SPRO

Spero Therapeutics, Inc. · Healthcare

Aquilo Capital Management, LLC bought $427K of Spero Therapeutics, Inc.

10% owner

Bought$427,227
$9.53Price
44,833Shares
+1%Stake

What SPRO did for a copier

Filed Mar 2, copier in the same day
$1,000 copied at Wed, Mar 2 close, $9.54
$684
S&P 500, same days
+1.6%

Measured over 30 trading days, to the Apr 13 close.

Aquilo Capital Management, LLC's record

12 other buys with 3 months of prices since 2021: on average −56.4% against the S&P 500, and 0 of 12 beat it.

We're building an app that can copy buys like this into your own brokerage. Join the waitlist

Traded Mon, Feb 28. Filed Wed, Mar 2, 3:52 PM ET, during the session. Returns use the Mar 2 close and the Apr 13 close. Not investment advice.